4//SEC Filing
Rome Zachary 4
Accession 0001104659-22-046471
CIK 0001504167other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 4:10 PM ET
Size
11.4 KB
Accession
0001104659-22-046471
Insider Transaction Report
Form 4
Rome Zachary
DirectorExecutive VP, COO and Sec.
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2022-03-04$0.01/sh+79,326$793→ 79,326 total - Tax Payment
Common Stock, par value $0.001 per share
2022-03-04$0.28/sh−19,630$5,496→ 59,696 total - Disposition to Issuer
Value Appreciation Rights
2022-03-04−52,884→ 79,326 totalExercise: $0.01From: 2022-03-04Exp: 2029-03-01→ Common Stock, par value $0.001 per share (52,884 underlying) - Exercise/Conversion
Value Appreciation Rights
2022-03-04+79,326→ 0 totalExercise: $0.01From: 2022-03-04Exp: 2029-03-01→ Common Stock, par value $0.001 per share (79,326 underlying)
Footnotes (2)
- [F1]Represents shares of common stock, par value $0.001 per share (the "Common Stock") of Timber Pharmaceuticals, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations on the exercise of value appreciation rights ("VARs").
- [F2]The VARs were to vest in five equal annual installments commencing on March 1, 2019, so long as the Reporting Person remained employed by the Issuer or its affiliates. The Reporting Person stepped down from his positions as the Chief Operating Officer and Executive Vice President of the Issuer effective March 4, 2022. As a result, the VARs were exercisable as of March 4, 2022.
Documents
Issuer
Timber Pharmaceuticals, Inc.
CIK 0001504167
Entity typeother
Related Parties
1- filerCIK 0001809611
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 4:10 PM ET
- Size
- 11.4 KB